110 related articles for article (PubMed ID: 22280200)
1. Methods and issues associated with the use of quality-adjusted life-years.
Revicki DA; Lenderking WR
Expert Rev Pharmacoecon Outcomes Res; 2012 Feb; 12(1):105-14. PubMed ID: 22280200
[TBL] [Abstract][Full Text] [Related]
2. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
Griebsch I; Coast J; Brown J
Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
[TBL] [Abstract][Full Text] [Related]
3. Preferences for health outcomes and cost-utility analysis.
Torrance GW
Am J Manag Care; 1997 May; 3 Suppl():S8-20. PubMed ID: 10180342
[TBL] [Abstract][Full Text] [Related]
4. Should "standard gamble" and "'time trade off" utility measurement be used more in mental health research?
Flood C
J Ment Health Policy Econ; 2010 Jun; 13(2):65-72. PubMed ID: 20919593
[TBL] [Abstract][Full Text] [Related]
5. Preference-based quality of life measures in people with visual impairment.
Kymes SM; Lee BS
Optom Vis Sci; 2007 Aug; 84(8):809-16. PubMed ID: 17700344
[TBL] [Abstract][Full Text] [Related]
6. The value-based medicine comparative effectiveness and cost-effectiveness of penetrating keratoplasty for keratoconus.
Roe RH; Lass JH; Brown GC; Brown MM
Cornea; 2008 Oct; 27(9):1001-7. PubMed ID: 18812762
[TBL] [Abstract][Full Text] [Related]
7. Community or patient preferences for cost-effectiveness of cardiac rehabilitation: does it matter?
Oldridge N; Furlong W; Perkins A; Feeny D; Torrance GW
Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):608-15. PubMed ID: 18800005
[TBL] [Abstract][Full Text] [Related]
8. [Assessment of health related quality of life--Part 1--Direct measures].
Horowitz E; Hassidim H; Abadi-Korek I; Shemer J
Harefuah; 2008; 147(8-9):731-4, 748. PubMed ID: 18935765
[TBL] [Abstract][Full Text] [Related]
9. Advantages and limitations of utility assessment methods in rheumatoid arthritis.
Beresniak A; Russell AS; Haraoui B; Bessette L; Bombardier C; Duru G
J Rheumatol; 2007 Nov; 34(11):2193-200. PubMed ID: 17937471
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of multilevel hemilaminectomy for lumbar stenosis-associated radiculopathy.
Parker SL; Fulchiero EC; Davis BJ; Adogwa O; Aaronson OS; Cheng JS; Devin CJ; McGirt MJ
Spine J; 2011 Aug; 11(8):705-11. PubMed ID: 21641874
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness analysis in severe mental illness: outcome measures selection.
Stant AD; Buskens E; Jenner JA; Wiersma D; TenVergert EM
J Ment Health Policy Econ; 2007 Jun; 10(2):101-8. PubMed ID: 17603150
[TBL] [Abstract][Full Text] [Related]
12. Evaluating health services: the importance of patients' preferences and quality of life.
Yin D; Forman HP; Langlotz CP
AJR Am J Roentgenol; 1995 Dec; 165(6):1323-8. PubMed ID: 7484556
[TBL] [Abstract][Full Text] [Related]
13. Preference-based measures in economic evaluation in health care.
Neumann PJ; Goldie SJ; Weinstein MC
Annu Rev Public Health; 2000; 21():587-611. PubMed ID: 10884966
[TBL] [Abstract][Full Text] [Related]
14. Trends in the measurement of health utilities in published cost-utility analyses.
Brauer CA; Rosen AB; Greenberg D; Neumann PJ
Value Health; 2006; 9(4):213-8. PubMed ID: 16903990
[TBL] [Abstract][Full Text] [Related]
15. Health-related quality of life after stroke: review of the literature and implications for future research.
Tseng MC; Lin HJ
Acta Neurol Taiwan; 2007 Mar; 16(1):7-12. PubMed ID: 17486727
[TBL] [Abstract][Full Text] [Related]
16. Health outcomes in economic evaluation: the QALY and utilities.
Whitehead SJ; Ali S
Br Med Bull; 2010; 96():5-21. PubMed ID: 21037243
[TBL] [Abstract][Full Text] [Related]
17. Tamoxifen for breast cancer risk reduction: impact of alternative approaches to quality-of-life adjustment on cost-effectiveness analysis.
Melnikow J; Birch S; Slee C; McCarthy TJ; Helms LJ; Kuppermann M
Med Care; 2008 Sep; 46(9):946-53. PubMed ID: 18725849
[TBL] [Abstract][Full Text] [Related]
18. Willingness to pay for a quality-adjusted life year: implications for societal health care resource allocation.
King JT; Tsevat J; Lave JR; Roberts MS
Med Decis Making; 2005; 25(6):667-77. PubMed ID: 16282217
[TBL] [Abstract][Full Text] [Related]
19. Relationship between quality of life instruments, health state utilities, and willingness to pay in patients with asthma.
Blumenschein K; Johannesson M
Ann Allergy Asthma Immunol; 1998 Feb; 80(2):189-94. PubMed ID: 9494453
[TBL] [Abstract][Full Text] [Related]
20. A utility-theoretic model for QALYs and willingness to pay.
Klose T
Health Econ; 2003 Jan; 12(1):17-31. PubMed ID: 12483758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
